News

Sensius: First joint EBAN Scaleup of the month May-2018

Sensius: First joint EBAN Scaleup of the month May-2018

31 May 2018 On May 31, 2018 the European Business Angels Network (EBAN) and the European Agency for Small and ...
Read More
2nd Annual ESHO Sensius Young Investigators Award

2nd Annual ESHO Sensius Young Investigators Award

19 May, 2018 Sensius is sponsor of the European Society for Hyperthermic Oncology (ESHO). During the annual conference in May ...
Read More
New! Advisory Board Sensius

New! Advisory Board Sensius

1 May, 2018 In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on ...
Read More

Sensius won the Venture Cup Award of Startup Olé Salamanca

19 April 2018 Sensius won the Venture Cup Award of Startup Olé SalamancaCompanies with the European Seal of Excellence from ...
Read More
Interview Life Sciences & Health 010 magazine

Interview Life Sciences & Health 010 magazine

February 2018 In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 ...
Read More

Pitch during Innovation for Health

Februari 2018 In February 2018 Sensius was invited for a pitch among other Dutch innovative startups during the congress Innovation ...
Read More

“High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer”

Rotterdam, 24 December 2017 MedValue: “High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer” The ...
Read More

Gerard van Rhoon receives Robinson Award

Gerard van Rhoon was honored by receiving the 28th J. Eugene Robinson1 award, which is the most prestigious price of ...
Read More

Sarah Brueningk receives Sensius Award at ESHO2017

At ESHO2017 in Athens, Sarah Brueningk received the Sensius Young Investigator Award for her presentation "Simulating response to multimodality therapies ...
Read More

Sensius receives first investment from UNIIQ for the HyperCollar3D

Sensius, an Erasmus MC Spinoff company developing novel cancer treatment using hyperthermia, is receiving €300,000 from the UNIIQ investment fund ...
Read More

Comments are closed.